Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study aims to identify the expression signature of miR-181a, miR-196a and miR-21 in
plasma of SLE patients and difference in their expression among groups with different
systemic lupus erythematosis disease activity index (SLEDAI) scores.